Corrigendum: Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390
Saved in:
Main Authors: | Xiaozhi Lv (Author), Junyan Wu (Author), Herui Yao (Author), Suiwen Ye (Author), Nan Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390
by: Xiaozhi Lv, et al.
Published: (2022) -
Effect of Efavirenz on the Pharmacokinetics of SHR6390 in Healthy Volunteers
by: Wang J, et al.
Published: (2024) -
Evaluation of the Effect of Food on the Pharmacokinetics of SHR6390, An Oral CDK4/6 Inhibitor, in Healthy Volunteers
by: Yan-ping Liu, et al.
Published: (2022) -
A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans
by: Hua Zhang, et al.
Published: (2023) -
Corrigendum: Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers
by: Yingzi Cui, et al.
Published: (2022)